Residual Pain in the Context of Selecting and Switching Biologic Therapy in Inflammatory Rheumatic Diseases

Residual Pain in the Context of Selecting and Switching Biologic Therapy in Inflammatory Rheumatic Diseases

For many years, inflammatory rheumatic diseases (IRDs) represented a source of disappointment in medical care caused by the mediocre efficacy of the available treatments. Some of these diseases, like Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS), caused fear in the general population, esp...

Full description

Bibliographic Details
Main Authors: Florian Berghea, Camelia Elena Berghea, Dumitru Zaharia, Andreea Iulia Trandafir, Elena Cristina Nita, Violeta Maria Vlad
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Medicine
Subjects:
residual pain
biologic therapy
rheumatod arthritis
ankilosing spondylitis
remission
switch
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.712645/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.712645/full

Similar Items